Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2011 1
2018 1
2019 5
2020 2
2021 2
2022 2
2023 3
2024 17
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.
Wallen ZD, Nesline MK, Tierno M, Roos A, Schnettler E, Husain H, Sathyan P, Caveney B, Eisenberg M, Severson EA, Ramkissoon SH. Wallen ZD, et al. Among authors: nesline mk. Front Oncol. 2024 Nov 27;14:1473327. doi: 10.3389/fonc.2024.1473327. eCollection 2024. Front Oncol. 2024. PMID: 39664186 Free PMC article.
Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratory.
Strickland KC, Nesline MK, Previs RA, Ko H, Cooper M, Rushton JR, Wallen ZD, Pabla S, Conroy JM, Sausen M, Saini KS, Cantini L, Jensen TJ, Caveney BJ, Eisenberg M, Severson EA, Ramkissoon S. Strickland KC, et al. Among authors: nesline mk. Front Oncol. 2024 Oct 31;14:1445668. doi: 10.3389/fonc.2024.1445668. eCollection 2024. Front Oncol. 2024. PMID: 39544293 Free PMC article.
A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumors.
Wallen ZD, Nesline MK, Pabla S, Gao S, Vanroey E, Hastings SB, Ko H, Strickland KC, Previs RA, Zhang S, Conroy JM, Jensen TJ, George E, Eisenberg M, Caveney B, Sathyan P, Ramkissoon S, Severson EA. Wallen ZD, et al. Among authors: nesline mk. Brief Bioinform. 2024 Sep 23;25(6):bbae557. doi: 10.1093/bib/bbae557. Brief Bioinform. 2024. PMID: 39471413 Free PMC article.
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer.
Ko HC, Seager RJ, Pabla S, Senosain MF, Van Roey E, Gao S, Strickland KC, Previs RA, Green MF, Cooper M, Nesline MK, Hastings SB, Amoah KA, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S. Ko HC, et al. Among authors: nesline mk. Breast Cancer (Dove Med Press). 2024 Aug 23;16:483-495. doi: 10.2147/BCTT.S476394. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 39192887 Free PMC article.
4-1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4-1BB agonists.
Uehara Y, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Pabla S, Conroy JM, DePietro P, Ko H, Sicklick JK, Kurzrock R. Uehara Y, et al. Among authors: nesline mk. Cancer Commun (Lond). 2024 Oct;44(10):1168-1172. doi: 10.1002/cac2.12592. Epub 2024 Aug 4. Cancer Commun (Lond). 2024. PMID: 39097973 Free PMC article. No abstract available.
Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer.
Wallen ZD, Ko H, Nesline MK, Hastings SB, Strickland KC, Previs RA, Zhang S, Pabla S, Conroy J, Jackson JB, Saini KS, Jensen TJ, Eisenberg M, Caveney B, Sathyan P, Severson EA, Ramkissoon SH. Wallen ZD, et al. Among authors: nesline mk. Front Immunol. 2024 Jun 21;15:1413956. doi: 10.3389/fimmu.2024.1413956. eCollection 2024. Front Immunol. 2024. PMID: 38975340 Free PMC article.
TIM-3 transcriptomic landscape with clinical and immunomic correlates in cancer.
Ahmed J, Nishizaki D, Miyashita H, Lee S, Nesline MK, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kato S, Kurzrock R. Ahmed J, et al. Among authors: nesline mk. Am J Cancer Res. 2024 May 15;14(5):2493-2506. doi: 10.62347/MQFF6404. eCollection 2024. Am J Cancer Res. 2024. PMID: 38859842 Free PMC article.
Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer.
Seager RJ, Ko H, Pabla S, Senosain MF, Kalinski P, Van Roey E, Gao S, Strickland KC, Previs RA, Nesline MK, Hastings S, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S. Seager RJ, et al. Among authors: nesline mk. J Pers Med. 2024 Apr 30;14(5):481. doi: 10.3390/jpm14050481. J Pers Med. 2024. PMID: 38793063 Free PMC article.
36 results